Morningstar has it as a Reduce at the moment which they didn't mention. Agreed that its a fantastic company though with massive growth potential still under the belt.
But good healthcare stocks are expensive on the ASX atm supposedly because there's relatively few of them. My understanding is that they are currently better value on overseas markets, perhaps with the exception of the US which is expensive atm generally.
Ann: Half Year Results Analyst Presentation, page-176
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$306.60 |
Change
4.560(1.51%) |
Mkt cap ! $148.1B | |||
| Open | High | Low | Value | Volume |
| $303.41 | $306.68 | $303.01 | $215.1M | 707.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3499 | $306.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $306.68 | 284 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |